ijms-logo

Journal Browser

Journal Browser

Recent Advances in Neurofibromatosis Type 1: From Molecular Insights to Novel Therapies

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 October 2025 | Viewed by 68

Special Issue Editors


E-Mail Website
Guest Editor
1. Department of Family Care Methodology, Institute of Health Science, Semmelweis University, 1085 Budapest, Hungary
2. Department of Internal Medicine, Heim Pal National Pediatric Institute, 1089 Budapest, Hungary
Interests: pediatrics; molecular genetics

E-Mail Website
Guest Editor
Department of Dermatology, Venereology and Dermatooncology, Faculty of Medicine, Semmelweis University, 1085 Budapest, Hungary
Interests: genodermatosis; neurocutaneous syndromes; clinical genetics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Neurofibromatosis type 1 (NF1) is a complex genetic disorder caused by pathogenic variants in the NF1 gene, leading to a wide spectrum of clinical manifestations, including benign and malignant tumors. While research on genotype-phenotype correlations is still limited, recent studies are increasingly focused on understanding these relationships to enhance patient management. Significant progress has been made in targeted therapies, such as MEK inhibitors, which have demonstrated promising results in reducing plexiform neurofibroma volumes in clinical trials. Furthermore, ongoing investigations are exploring the role of mast cells and fibroblasts in the tumor microenvironment, as well as novel agents targeting the Ras/MAPK pathway. Advanced imaging techniques and emerging biomarkers are also improving early diagnosis and monitoring of malignant transformations, such as in malignant peripheral nerve sheath tumors (MPNSTs). This Special Issue aims to highlight the latest scientific discoveries, from molecular research to innovative clinical interventions, to better understand the disease and improve patient outcomes and quality of life. Imaging studies with promising diagnostic approaches are also welcome.

This Special Issue is supervised by Prof. Dr. László Szabó and Dr. Márta Medvecz, and assisted by Dr. Klára Veres (Heim Pál National Pediatric Institute).

Dr. László Szabó
Dr. Márta Medvecz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurofibromatosis type 1
  • genotype–phenotype analyses
  • molecular pathogenesis
  • next-generation sequencing (NGS)
  • molecular targeted therapy
  • MEK inhibitors
  • imaging studies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop